Bank of New York Mellon’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-149,996
| Closed | -$16.1M | – | 4492 |
|
|
2023
Q1 | $16.1M | Sell |
149,996
-1,206
| -0.8% | -$129K | ﹤0.01% | 1665 |
|
|
2022
Q4 | $16.6M | Buy |
151,202
+27,505
| +22% | +$3.03M | ﹤0.01% | 1636 |
|
|
2022
Q3 | $7.3M | Buy |
123,697
+26,852
| +28% | +$1.58M | ﹤0.01% | 2092 |
|
|
2022
Q2 | $2.74M | Sell |
96,845
-31,781
| -25% | -$898K | ﹤0.01% | 2656 |
|
|
2022
Q1 | $4.86M | Buy |
128,626
+11,844
| +10% | +$447K | ﹤0.01% | 2446 |
|
|
2021
Q4 | $4.62M | Buy |
116,782
+82,928
| +245% | +$3.28M | ﹤0.01% | 2503 |
|
|
2021
Q3 | $803K | Buy |
33,854
+2,450
| +8% | +$58.1K | ﹤0.01% | 3527 |
|
|
2021
Q2 | $771K | Buy |
+31,404
| New | +$771K | ﹤0.01% | 3566 |
|